查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1522738

全球连续血糖监测市场评估：按组成部分、年龄层、糖尿病类型、最终用户、地区、机会、预测，2017-2031

Continuous Glucose Monitoring Market Assessment, By Component, By Age Group, By Diabetes Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 233 Pages | 商品交期: 3-5个工作天内

价格

预计2024-2031年期间，全球连续血糖监测（CGM）市场规模将以11.13%的复合年增长率扩大，并预计将持续成长到2031年。连续血糖监测市场是医疗器材产业不可或缺的一部分，也是成长最快的市场之一。糖尿病盛行率的增加、持续血糖监测设备的日益普及、糖尿病监测意识的增强以及技术的进步正在推动市场的发展。

连续血糖监测设备使用血糖水平测量来透过最大限度地减少指尖采血测试来管理糖尿病。透过放置在患者皮肤上或皮肤下的感测器全天连续测量血糖水平。发射器可以与智慧型手錶等穿戴式装置结合使用，以显示任何给定时间点的血糖水平变化。也就是说，使用 CGM 进行糖尿病管理简化了流程，但需要一些时间来适应。使用 CGM 数据时，范围内时间方法除了计算患者处于所需血糖值测量范围内的时间之外，还计算血糖高于（高血糖）或低于（低血糖）正常水平的次数。血糖仪可对一个人的血糖值进行单点估计，但 CGM 设备可提供更广泛的血糖模式视图。多项研究证明 CGM 设备可以帮助使用者将血糖值保持在一定范围内，消除低血糖和高血糖，并减少糖尿病相关问题的可能性。也就是说，使用 CGM 是一个长期的解决方案。

随着糖尿病患者数量的增加，对 CGM 的需求也显着增加。2,300 万名糖尿病患者中有 31% 接受胰岛素治疗，并且可以使用连续血糖监测 (CGM)。美国糖尿病协会推荐CGM作为第1型糖尿病患者治疗的黄金标准，也是接受胰岛素治疗的第二型糖尿病患者的重要装置。综上所述，不断增加的糖尿病患者数量增加了对连续血糖监测设备的需求，这可以显着改善血糖控制并改善糖尿病患者的健康状况。随着糖尿病患者人数的增加，获得这项技术已成为当务之急。

该报告研究了全球连续血糖监测市场，并提供了市场概述，包括按成分、年龄组、糖尿病类型、最终用户、区域趋势以及参与该市场的公司的概况。

目录

第1章 研究方法论

第2章 专案范围与定义

第3章 执行摘要

第4章 2017-2031 年全球连续血糖监测市场展望

  • 市场规模及预测
  • 按组件
  • 按年龄段
  • 依糖尿病类型
  • 按最终用户
  • 按地区
  • 按公司划分的市占率 (%)，2023 年

第五章全球连续血糖监测市场展望（按地区，2017-2031）

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第6章 市场测绘，2023 年

第7章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第8章 市场动态

第9章 监理架构与创新

第10章 主要与企业状况

第11章 价格分析

第12章 案例研究

第13章 主要进入者展望

  • Abbott Laboratories
  • Medtronic Plc
  • Ypsomed AG
  • Senseonics Holdings Inc.
  • Insulet Corporation
  • Medtrum Technologies
  • Nemaura Medical Inc
  • Menarini Diagnostics S.A
  • Dexcom Inc
  • F.Hoffman-La Roche Ltd.

第14章 战略建议

第15章 查询及免责声明

Product Code: MX11675

Global continuous glucose monitoring market is projected to witness a CAGR of 11.13% during the forecast period 2024-2031, growing from USD 5.75 in 2023 to USD 13.38 in 2031. The continuous glucose monitoring market is an integral part of the medical device industry, accounting for one of the fastest growth rates. Factors are driving the market such as the increasing prevalence of diabetes, the growing adoption of CGM devices, increasing awareness about diabetes monitoring, and technological advancements.

Continuous glucose monitoring devices use glucose level measurements to manage diabetes by minimizing fingerstick tests. Continuous glucose levels are measured throughout the day by a sensor located on or beneath the patient's skin. A transmitter can be used together with some wearable appliance, for instance, a smartwatch, to display changes in blood sugar levels at any given moment of time. Nevertheless, it takes a while to adjust to using a CGM for diabetes management, although it simplifies the process. When CGM data is being utilized, the time-in-range method measures the duration patients have been within the desired glucose levels in addition to a number of times that their glucose has risen above (hyperglycemia) or gone below normal levels (hypoglycemia). A blood glucose meter provides a single-point estimate of a person's blood sugar level, while a CGM device offers a broader perspective on patterns in relation to glucose. It has been demonstrated in several studies that CGM devices help users keep their glucose levels at a constant range, eliminate low and high glucose levels cases, and reduce the chances of coming up with problems that are related to diabetes. Nevertheless, using CGM is a long-term solution.

In March 2024, Roche presented new continuous glucose monitoring technology with artificial intelligence at a conference on Advanced Technologies & Treatments for Diabetes in Italy. The company revealed its Accu-Chek SmartGuide. The device is under research and has not yet been approved for retail sales. There are several characteristics that Abbott and Dexcom CGMs and the Accu-Chek SmartGuide have in common. It has waterproof qualities, a one-step application technique, and a 14-day wear time. On the other hand, unlike some of the newest generation of devices, this CGM needs initial calibration.

Increasing Prevalence of Diabetes Globally

The demand for CGM has increased significantly along with the number of individuals with diabetes. 31% of the 23 million Americans who have diabetes receive insulin treatment, which enables them to use continuous glucose monitoring (CGM). The American Diabetes Association recommends CGM as the gold standard of treatment for those with type 1 diabetes and a crucial device for patients with type 2 diabetes undergoing insulin therapy. In conclusion, the increasing number of people with diabetes is driving demand for continuous glucose monitoring devices, which may significantly improve glucose control and health outcomes for those with the disease. With the increasing number of diabetic people, access to this technology is becoming a priority.

Technological Advancements to Increase Market Demand

The field of CGM technology is continually evolving, with numerous research projects and clinical trials underway. Diabetes is a significant healthcare challenge, and the potential for improving patient outcomes through CGM technology remains effective. Artificial intelligence and machine learning are expected to significantly evolve the role of CGM technology. These advancements will make artificial pancreas systems more precise and sensitive, allowing patients to live their lives naturally without being controlled by their diabetes. Dexcom introduced Dexco ONE+, a real-time continuous glucose monitoring device in Poland, Spain, and Belgium, in February 2024. On February 12th, the business introduced its CGM device in the Netherlands. In the upcoming months, Dexcom plans to introduce Dexcom ONE+ in the Middle East and Africa and other European nations. The Dexcom ONE+ system is made up of a transmitter that transmits CGM data, a water-resistant blood glucose sensor, and an application that works with smartphones to access the Dexcom One app.

Sensors Dominate the Component Segment in the Global Continuous Monitoring Market

Based on components, the sensors account for the highest share in the continuous glucose monitoring market. CGM sensors calculate the glucose level in the fluids between cells, and it is quite comparable to the glucose levels in the blood. Depending on the type of sensor a patient has, it may be necessary to change it every few weeks or at other specified intervals. Depending on the model, disposable CGM sensors need to be changed every 7 to 14 days. A few implanted sensors have a 180-day lifespan. Abbott introduced two over-the-counter glucose monitors in the United States in June 2024, competing against Dexcom's Stelo. Abbott had planned to launch Lingo in the United States after its release in the United Kingdom last year. The device analyzes glucose levels over the course of 14 days and can be worn on the upper arm to assist users in better understanding how their bodies respond to various diets, physical activities, and stresses. Abbott was given FDA approval on May 29th, 2024, to market its Lingo system without a prescription.

Home Care Settings Will Hold the Highest Share in the Forecast Period

In the future, home care settings are expected to witness a significant increase in demand for continuous glucose monitoring (CGM) devices. As the technology develops, with longer sensor wear times, more accuracy, and easier smartphone connection, CGM will become a more alluring alternative for home-based diabetes care. Compared to traditional self-monitoring, continuous glucose monitoring (CGM) is more convenient and is likely to increase adherence since it eliminates the need for fingerstick tests. By enabling patients to actively control their disease and prevent complications, more widespread utilization of CGM has the potential to revolutionize the way diabetes is treated. The use of these devices in homes is expected to increase in the upcoming years as they become more widely available and affordable.

Key Players Landscape and Outlook

Several medical device companies are flourishing in the continuous glucose monitoring market by planning and adopting new strategies. They are complying with new strategic initiatives for medical devices to increase their market presence. New agreements, contracts, acquisitions, mergers, investments, and partnerships are major ways through which they are trying to achieve higher market share.

In May 2024, Sensonics, a globally renowned manufacturer of implantable CGM systems, announced its partnership with Rimidi. The main aim of this collaboration is to formulate the Eversense Remote Patient Monitoring (RPM) Program, which will combine healthcare workflows easily. The Eversense CGM + RPM solution will integrate Rimidi's clinical management platform with Senseonic's durable Eversense sensor.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Continuous Glucose Monitoring Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Component
    • 4.2.1. Transmitters
    • 4.2.2. Receivers
    • 4.2.3. Sensors
  • 4.3. By Age Group
    • 4.3.1. Children
    • 4.3.2. Adults
    • 4.3.3. Geriatric
  • 4.4. By Diabetes Type
    • 4.4.1. Type-1 Diabetes
    • 4.4.2. Type-2 Diabetes
  • 4.5. By End-user
    • 4.5.1. Hospitals
    • 4.5.2. Home Care Settings
    • 4.5.3. ICU
    • 4.5.4. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Continuous Glucose Monitoring Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Component
      • 5.1.2.1. Transmitters
      • 5.1.2.2. Receivers
      • 5.1.2.3. Sensors
    • 5.1.3. By Age Group
      • 5.1.3.1. Children
      • 5.1.3.2. Adults
      • 5.1.3.3. Geriatric
    • 5.1.4. By Diabetes Type
      • 5.1.4.1. Type-1 Diabetes
      • 5.1.4.2. Type-2 Diabetes
    • 5.1.5. By End-user
      • 5.1.5.1. Hospitals
      • 5.1.5.2. Home Care Settings
      • 5.1.5.3. ICU
      • 5.1.5.4. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
        • 5.1.6.1.1. By Value
        • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Component
        • 5.1.6.2.1. Transmitters
        • 5.1.6.2.2. Receivers
        • 5.1.6.2.3. Sensors
      • 5.1.6.3. By Age Group
        • 5.1.6.3.1. Children
        • 5.1.6.3.2. Adults
        • 5.1.6.3.3. Geriatric
      • 5.1.6.4. By Diabetes Type
        • 5.1.6.4.1. Type-1 Diabetes
        • 5.1.6.4.2. Type-2 Diabetes
      • 5.1.6.5. By End-user
        • 5.1.6.5.1. Hospitals
        • 5.1.6.5.2. Home Care Settings
        • 5.1.6.5.3. ICU
        • 5.1.6.5.4. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Component
  • 6.2. By Age Group
  • 6.3. By Diabetes Type
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Abbott Laboratories
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Medtronic Plc
  • 13.3. Ypsomed AG
  • 13.4. Senseonics Holdings Inc.
  • 13.5. Insulet Corporation
  • 13.6. Medtrum Technologies
  • 13.7. Nemaura Medical Inc
  • 13.8. Menarini Diagnostics S.A
  • 13.9. Dexcom Inc
  • 13.10. F.Hoffman-La Roche Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 4. Global Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 5. Global Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 6. Global Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Continuous Glucose Monitoring Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 10. North America Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 11. North America Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 12. North America Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 13. North America Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Continuous Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 17. United States Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 18. United States Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 19. United States Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 20. United States Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 23. Canada Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 24. Canada Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 25. Canada Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 26. Canada Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 29. Mexico Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 30. Mexico Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 31. Mexico Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 32. Mexico Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 35. Europe Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 36. Europe Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 37. Europe Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 38. Europe Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Continuous Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 42. Germany Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 43. Germany Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 44. Germany Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 45. Germany Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 48. France Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 49. France Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 50. France Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 51. France Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 54. Italy Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 55. Italy Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 56. Italy Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 57. Italy Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 60. United Kingdom Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 61. United Kingdom Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 62. United Kingdom Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 63. United Kingdom Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 66. Russia Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 67. Russia Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 68. Russia Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 69. Russia Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 72. Netherlands Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 73. Netherlands Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 74. Netherlands Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 75. Netherlands Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 78. Spain Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 79. Spain Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 80. Spain Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 81. Spain Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 84. Turkey Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 85. Turkey Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 86. Turkey Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 87. Turkey Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 90. Poland Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 91. Poland Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 92. Poland Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 93. Poland Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 96. South America Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 97. South America Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 98. South America Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 99. South America Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Continuous Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 103. Brazil Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 104. Brazil Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 105. Brazil Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 106. Brazil Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 109. Argentina Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 110. Argentina Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 111. Argentina Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 112. Argentina Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 115. Asia-Pacific Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 116. Asia-Pacific Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 117. Asia-Pacific Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 118. Asia-Pacific Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Continuous Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 120. India Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 122. India Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 123. India Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 124. India Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 125. India Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 128. China Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 129. China Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 130. China Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 131. China Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 134. Japan Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 135. Japan Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 136. Japan Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 137. Japan Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 140. Australia Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 141. Australia Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 142. Australia Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 143. Australia Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 146. Vietnam Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 147. Vietnam Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 148. Vietnam Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 149. Vietnam Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 152. South Korea Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 153. South Korea Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 154. South Korea Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 155. South Korea Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 158. Indonesia Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 159. Indonesia Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 160. Indonesia Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 161. Indonesia Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 164. Philippines Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 165. Philippines Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 166. Philippines Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 167. Philippines Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 170. Middle East & Africa Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 171. Middle East & Africa Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 172. Middle East & Africa Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 173. Middle East & Africa Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Continuous Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 177. Saudi Arabia Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 178. Saudi Arabia Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 179. Saudi Arabia Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 180. Saudi Arabia Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 183. UAE Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 184. UAE Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 185. UAE Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 186. UAE Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 189. South Africa Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 190. South Africa Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
  • Figure 191. South Africa Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
  • Figure 192. South Africa Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Diabetes Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023